BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Genetown

  CENTOGENE to Participate in Upcoming Conferences in November 2022

  Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced its conference schedule for November 2022.

  November 10, 2022

   · 

  4 min read
• BioMidwest

  ViewRay® to Present at the Stifel 2022 Healthcare Conference

  ViewRay, Inc. announced that the Company will present at the Stifel 2022 Healthcare Conference.

  November 10, 2022

   · 

  1 min read
• Business

  Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results

  Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, reported recent business and pipeline progress and third quarter 2022 financial results.

  November 10, 2022

   · 

  12 min read
• Business

  BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

  BD, a leading global medical technology company, announced results for its fourth quarter and full year of fiscal 2022, which ended September 30, 2022.

  November 10, 2022

   · 

  19 min read
• Pharm Country

  Immunic to Participate in Investor and Scientific Conferences in November and December 2022

  Immunic, Inc. announced participation in the following investor and scientific conferences in November and December.

  November 10, 2022

   · 

  7 min read
• Genetown

  ROME Therapeutics Demonstrates Efficacy of its Novel LINE-1 Reverse Transcriptase Inhibitor in Translational Models of Autoimmune Disease

  ROME Therapeutics today announced it will share preclinical data from its lead program, a LINE-1 reverse transcriptase inhibitor, in a poster presentation at American College of Rheumatology (ACR) Convergence 2022, taking place November 10 – 14, 2022, in Philadelphia.

  November 10, 2022

   · 

  2 min read
• Business

  NRx Pharmaceuticals to Report Third Quarter 2022 Results on November 14, 2022

  NRx Pharmaceuticals, Inc. today announced that management will report third quarter 2022 financial results prior to the market open on November 14, 2022.

  November 10, 2022

   · 

  4 min read
• Drug Development

  Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage Choroidal Melanoma

  Aura Biosciences Inc. today announced that it has initiated startup activities for the global Phase 3 trial.

  November 10, 2022

   · 

  6 min read
• Immunocore to present at the 2022 Jefferies London Healthcare Conference

  Immunocore Holdings Plc announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference.

  November 10, 2022

   · 

  1 min read
• Business

  Iterum Therapeutics Reports Third Quarter 2022 Financial Results

  Iterum Therapeutics plc, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, reported financial results for the third quarter ended September 30, 2022.

  November 10, 2022

   · 

  14 min read